中国40岁及以上成人带状疱疹疫苗接种覆盖率及相关因素:一项基于人群的调查
该研究在中国大陆25个省份开展全国性调查,纳入14,315名40岁以上参与者,估算带状疱疹疫苗(HZV)接种率及相关因素。结果显示HZV接种率为0.79%,接种更常见于初中教育程度和较高家庭收入者,多数接种者使用带状疱疹减毒活疫苗(ZVL)而非重组带状疱疹疫苗(RZV),近半数完成两剂。结论认为中国HZV覆盖率低,需针对性公共卫生策略提高疫苗可及性和认知。
要点
- 中国40岁及以上成人HZV接种率为0.79%。
- 接种更常见于初中教育程度和较高家庭收入者。
- 多数接种者使用ZVL而非RZV,近半数完成两剂。
核心结论
- 中国HZV覆盖率低,需针对性公共卫生策略提高疫苗可及性和认知,尤其在高风险群体中,以减轻带状疱疹相关负担。
研究设计与样本
- 在中国大陆25个省份开展全国性调查,纳入14,315名40岁以上参与者,采用多变量logistic回归评估接种相关特征,并分析疫苗类型和剂量完成率。
主要发现
- HZV接种率为0.79%。
- 接种更常见于初中教育程度和较高家庭收入者。
- 多数接种者使用带状疱疹减毒活疫苗(ZVL)而非重组带状疱疹疫苗(RZV),近半数完成两剂。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Herpes zoster (HZ) is a significant public health issue in China, especially with an aging population and rising incidence. While vaccination effectively prevents HZ and its complications, national data on HZ vaccine (HZV) coverage and associated factors in China are limited. METHODS: We conducted a nationwide survey across 25 provinces in mainland China, including 14,315 participants aged over 40 years, to estimate HZV uptake and associated factors among adults aged 40 years and older. Multivariate logistic regression was used to assess characteristics linked to vaccination, and we analysed vaccine types and dose completion rates. RESULTS: The HZV uptake rate was 0.79 %. Vaccination was more likely among individuals with middle school education and higher household income. Most vaccinated individuals received the zoster vaccine live (ZVL) rather than the recombinant zoster vaccine (RZV), and nearly half completed two doses. CONCLUSIONS: HZV coverage in China is low, underscoring the need for targeted public health strategies to improve vaccine accessibility and awareness, particularly among at-risk groups, to reduce HZ-related burdens.
引用
- Xia Y, Zhu W, Shi Z, et al. Herpes zoster vaccination coverage and factors associated among adults aged 40 and older in China: A population-based survey. Vaccine. 2025. PMID: 40253789. doi:10.1016/j.vaccine.2025.127122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。